Related Experiment Videos
Abnormal bone marrow B-cell differentiation in pre-B lymphoma-prone SL/Kh mice
K Okamoto1, Y Yamada, M S Ogawa
1Department of Pathology, Faculty of Medicine, Kyoto University, Japan.
Cancer Research
|January 15, 1994
Summary
SL/Kh mice exhibit an unusual expansion of specific pre-B cells, a dominant inherited trait linked to their stem cells, predisposing them to lymphoma development.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- SL/Kh mice develop pre-B lymphomas with specific surface markers.
- These lymphomas show rearranged immunoglobulin heavy chains but germline light chains.
- Pre-lymphoma bone marrow in SL/Kh mice displays an abnormal expansion of BP-1+ pre-B cells.
Purpose of the Study:
- To investigate the cause of the multiclonal expansion of BP-1+ pre-B cells in SL/Kh mice.
- To determine if this expansion is a heritable trait and its genetic basis.
- To ascertain whether the expansion originates from bone marrow stem cells or the microenvironment.
Main Methods:
- Flow cytometry to analyze cell surface phenotypes (B220, BP-1, Thy-1, c-kit, surface immunoglobulin).
- Genetic crosses (F1 hybrids) to assess the heritability of the BP-1+ cell expansion.
- Radiation chimera experiments (SL/Kh --> BALB/c and BALB/c --> SL/Kh) to differentiate stem cell versus microenvironment contributions.
Main Results:
- SL/Kh mice show a significant expansion of BP-1+ pre-B cells (34.8%) compared to other strains (8%).
- This expansion is a dominant heritable trait in F1 hybrids of SL/Kh and NFS/N mice.
- The expansion is independent of endogenous ecotropic virus expression.
- Radiation chimeras demonstrated that the expansion is a property of SL/Kh stem cells, not the bone marrow microenvironment.
Conclusions:
- The multiclonal expansion of BP-1+ pre-B cells in SL/Kh mice is a dominant, heritable characteristic.
- This expansion originates from SL/Kh hematopoietic stem cells.
- These findings identify a critical cellular defect in SL/Kh mice that contributes to their spontaneous pre-B lymphoma development.